A 52-member business delegation accompanied President Moon Jae-in’s formal visit to the United States in late June, representing large enterprises, medium and small-sized companies in diverse areas, including medical industry, biotechnology and information technology. Mid-sized companies in the delegation included Osstem Implant Co., Ltd., a fast-growing dental technology and instruments company.

Aiming to grow into the world top implant technology company by 2023, Osstem Implant strives to provide total dental solutions and position as a leader in the global dental technology market. More than 300 scientists and researchers are engaged in developing dental technologies and products at 7 research institutions including an implant research institute, investing KRW30 billion (approx. $26.7 million) annually that is equivalent to 10% of its annual sales. The company is expanding technology and product areas from implants to dental equipments, materials and dental information technology essentially needed for dental care. High quality of its products is widely recognized in the international community as well as in Korea. It obtained quality certificates from major countries, such as the U.S. FDA and CE.

President Eom Tae-gwan of Osstem Implant

Since its establishment in 1997, the company has rapidly grown, achieving double-digit growth annually. As the fifth largest implant provider in the world as of 2014, Osstem Implant set an ambitious goal of growing as the world’s top implant company with annual sales revenue of KRW1.4 trillion (approx. $1.246 billion), gaining more than twice larger revenue within 6 years. Currently, it is exporting its products to over 70 countries, operating subsidiaries in 23 nations.
World top quality of implants and strong competitiveness are indebted to its extensive R&D investments. The company now has a variety of implant systems that can be adopted for diverse clinical cases, and it developed super-hydrophilic surface to improve osseointergration function and surface technology for weak quality of bones. In addition, it has developed heterogenous and alloplastic bones, as well as GBR tools. It also introduced various instruments that can help safe and convenient placement of implants.

“Researchers are core element of the company. Though it is difficult to invest 10% of sales revenue in R&D as sales rapidly increase in recent months, we are steadily investing over 7% annually for that purpose,” said Eom Tae-gwan, President of Osstem Implant. “We aim to grow into a world leader in dental technology that provides total dental solutions ranging from dental materials

Also, Osstem Implant is striving to enhance implant clinical knowledge and treatment capabilities of dentists. As an implant clinical education institution established in 2000 by Osstem Implant, AIC contributes to improvement of implant surgery and popularization by providing in-depth education programs on implant to dentists.and equipments to software for operating dental clinics and interior of clinics.”
Currently, Osstem Implant is developing dental equipments, dental materials and dental information technology as well as implants. Particularly, dental unit chairs which it started to produce in 2011 are well received by the market thanks to their sophisticated design, excellent quality and immediate post-sale service. Dental materials include bone substitutes, gingival enlargement materials, impression materials and teeth whiteners.

President Eom Tae-gwan said that his recent visit to the United States as a member of the business delegation accompanying the Presidential formal visit to that country significantly contributed to building a network with key U.S. officials and enhancing awareness of brand of the company.

저작권자 © The Korea Post 무단전재 및 재배포 금지